Budding of enveloped viruses from the plasma membrane

BioEssays

Volumn 19, Issue 11, 1997, Pages 993-1000

  Cadd, Tamarra L ^a   Skoging, Ulrica ^a   Liljeström, Peter ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031282106     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950191109     Document Type: Review

References (89)

1. Tashiro, M., McQueen, N. L., Seto, J. T., Klenk, H. D. and Rott, R. (1996). Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus. J. Virol. 70, 5990-5997.
2. Cattaneo, R. and Rose, J. K. (1993). Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J. Virol. 67, 1493-1502.
3. Zurbriggen, A., Graber, H. U. and Vandevelde, M. (1995). Selective spread and reduced virus release leads to canine distemper virus persistence in the nervous system. Vet. Microbiol. 44, 281-288.
4. Strauss, J. H. and Strauss, E. G. (1994). The alphaviruses: Gene expression, replication, and evolution. Microbiol. Revs 58, 491-562.
5. Schlesinger, S. and Schlesinger, M. J. 1996. Togaviridae: The viruses and their replication. In Fields Virology, 3rd edn, vol. 1. (ed. B. N. Fields, D. M. Knipe and P. M. Howley), pp. 825-841. Lippincott-Raven Publishers, Philadelphia.
6. Cheng, R. H., Kuhn, R. J., Olson, N. H., Rossmann, M. G., Choi, H. K., Smith, T. J. and Baker, T. S. (1995). Nucleocapsid and glycoprotein organization in an enveloped virus. Cell 80, 621-630.
7. Fuller, S. D., Berriman, J. A., Butcher, S. J. and Gowen, B. E. (1995). Low pH induces swiveling of the glycoprotein heterodimers in the Semliki Forest virus spike complex. Cell 81, 715-725.
8. Wahlberg, J. M., Bron, R., Wilschut, J. and Garoff, H. (1992). Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein. J. Virol. 66, 7309-7318.
9. Suomalainen, M., Liljeström, P. and Garoff, H. (1992). Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J. Virol. 66, 4737-4747.
10. Strauss, J. H., Strauss, E. G. and Kuhn, R. J. (1995). Budding of alphaviruses. Trends Microbiol. 3, 346-350.
11. Ivanova, L. and Schlesinger, M. J. (1993). Site-directed mutations in the Sindbis virus E2 glycoprotein identify palmitoylation sites and affect virus budding. J. Virol. 67, 2546-2551.
12. Zhao, H., Lindqvist, B., Garoff, H., von Bonsdorff, C. H. and Liljeström, P. (1994). A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding. EMBO J. 13, 4204-4211.
13. Lee, S. et al. (1996). Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly. Structure 4, 531-541.
14. Owen, K. E. and Kuhn, R. J. (1997). Alphavirus budding is dependent on the interaction between the nucleocapsid and hydrophobic amino acids on the cytoplasmic domain of the E2 envelope glycoprotein. Virology 230, 187-196.
15. Skoging, U., Vihinen, M., Nilsson, L. and Liljeström, P. (1996). Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid. Structure 4, 519-529.
16. Pavan, A. et al. (1992). Dynamics of transmembrane proteins during Sindbis virus budding. J. Cell Sci. 102, 149-155.
17. Ekström, M., Liljeström, P. and Garoff, H. (1994). Membrane protein lateral interactions control Semliki Forest virus budding. EMBO J. 13, 1058-1064.
18. Forsell, K., Griffiths, G. and Garoff, H. (1996). Preformed cytoplasmic nucleocapsids are not necessary for alphavirus budding. EMBO J. 15, 6495-6505.
19. Uiljeström, P., Lusa, S., Huylebroeck, D. and Garoff, H. (1991). In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the 6,000-molecular-weight membrane protein modulates virus release. J. Virol. 65, 4107-4113.
20. Loewy, A., Smyth, J., von Bonsdorff, C. H., Liljeström, P. and Schlesinger, M. J. (1995). The 6-kilodalton membrane protein of Semliki Forest virus is involved in the budding process. J. Virol. 69, 469-475.
21. Gaedigk-Nitschko, K. and Schlesinger, M. J. (1991). Site-directed mutations in Sindbis virus E2 glycoprotein's cytoplasmic domain and the 6K protein lead to similar defects in virus assembly and budding. Virology 183, 206-214.
22. Sanz, M. A., Perez, L. and Carrasco, L. (1994). Semliki Forest virus 6K protein modifies membrane permeability after inducible expression in Escherichia coli cells. J. Biol. Chem. 269, 12106-12110.
23. Lamb, R. A. and Kolakofsky, D. 1996. Paramyxoviridae: The viruses and their replication. In Fields Virology, 3rd edn, vol. 1. (ed. B. N. Fields, D. M. Knipe and P. M. Howley), pp. 1177-1204. Lippincott-Raven Publishers, Philadelphia.
24. Justice, P. A., Sun, W., Li, Y., Grigera, P. R. and Wagner, R. R. (1995). Membrane vesiculation function and exocytosis of wild type and mutant matrix proteins of vesicular stomatitis virus. J. Virol. 69, 3156-3160.
25. Mebatsion, T., König, M. and Conzelmann, K. K. (1996). Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 84, 941-951.
26. Enami, M. and Enami, K. (1996). Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J. Virol. 70, 6653-6657.
27. Kretzschmar, E., Bui, M. and Rose, J. K. (1996). Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology 220, 37-45.
28. Jin, H., Leser, G. P. and Lamb, R. A. (1994). The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J. 13, 5504-5515.
29. Garcia-Sastre, A. and Palese, P. (1995). The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in the packaging of this protein into viral envelopes. Virus Res. 37, 37-47.
30. Mitnaul, L. J., Castrucci, M. R., Murti, K. G. and Kawaoka, Y. (1996). The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J. Virol. 70, 873-879.
31. Jin, H., Leser, G. P., Zhang, J. and Lamb, R. A. (1997). Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J. 16, 1236-1247.
32. + target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein. Proc. Natl Acad. Sci. USA 93, 11366-11370.
33. Naim, H. Y. and Roth, M. G. (1993). Basis for selective incorporation of glycoproteins into the influenza virus envelope. J. Virol. 67, 4831-4841.
34. Schnell, M. J., Buonocore, L., Kretzschmar, E., Johnson, E. and Rose, J. K. (1996). Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc. Natl Acad. Sci. USA 93, 11359-11365.
35. Luan, P., Yang, L. and Glaser, M. (1995). Formation of membrane domains created during the budding of vesicular stomatitis virus. A model for selective lipid and protein sorting in biological membranes. Biochemistry 34, 9874-9883.
36. 2+ on morphogenesis of HVJ (Sendai virus) in LLC-MK2 cells: effects on phosphorylated M protein associated with viral morphogenesis. Cell Struc. Func. 19, 325-333.
37. Coffin, J. M. 1996. Retroviridae: The viruses and their replication. In Fields Virology, 3rd edn, vol. 1. (ed. B. N. Fields, D. M. Knipe and P. M. Howley), pp. 1767-1847. Lippincott-Raven Publishers, Philadelphia.
38. Rhee, S. S. and Hunter, E. (1990). A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 63, 77-86.
39. Delchambre, M. et al. (1989). The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J. 8, 2653-2660.
40. Gheysen, D. et al. (1989). Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59, 103-112.
41. Zhou, W., Parent, L. J., Wills, J. W. and Resh, M. D. (1994). Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68, 2556-2569.
42. Nelle, T. D. and Wills, J. W. (1996). A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity. J. Virol. 70, 2269-2276.
43. Morikawa, Y. et al. (1996). Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding. J. Biol. Chem. 271, 2868-2873.
44. Zhou, W. J. and Resh, M. D. (1996). Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70, 8540-8548.
45. Barklis, E. et al. (1997). Structural analysis of membrane-bound retrovirus capsid proteins. EMBO J. 16, 1199-1213.
46. Gitti, R., Lee, B., Walker, J., Summes, M., Yoo, S. and Sundquist, W. I. (1996). Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273, 231-235.
47. Momany, C. et al. (1996). Crystal structure of dimeric HIV-1 capsid protein. Nature Struct. Biol. 3, 763-770.
48. Nermut, M. V., Hockley, D. J., Jowett, J. B. M., Jones, I. M., Garreau, M. and Thomas, D. (1994). Fullerene-like organization of HIV gag-protein shell in virus-like partciles produced by recombinant baculovirus. Virology 198, 288-296.
49. Rao, Z., Belyaev, A. S., Fry, E., Roy, P., Jones, I. M. and Stuart, D. I. (1995). Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378, 743-747.
50. Freed, O. E. and Martin, M. A. (1996). Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70, 341-351.
51. Dorfman, T., Mammano, F., Haseltine, W. A. and Göttlinger, H. G. (1994). Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68, 1689-1696.
52. Lodge, R., Lalonde, J. P., Lemay, G. and Cohen, E. A. (1997). The membraneproximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J. 16, 695-705.
53. Lee, Y. M., Tang, X. B., Cimakasky, L. M., Hildreth, J. E. K. and Yu, X. F. (1997). Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4(+) T lymphocytes. J. Virol. 71, 1443-1452.
54. Cosson, P. (1996). Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15, 5783-5788.
55. Salzwedel, K., Johnston, P. B., Roberts, S. J., Dubay, J. W. and Hunter, E. (1993). Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 67, 5279-5288.
56. Wilk, T., Pfeiffer, T. and Bosch, V. (1992). Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189, 167-177.
57. Gabuzda, D. H., Lever, A., Terwillinger, E. and Sodroski, J. (1992). Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66, 3306-3315.
58. Freed, E. O. and Martin, M. A. (1995). Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid subsitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69, 1984-1989.
59. Mammano, F., Kondo, E., Sodroski, J., Bukovsky, A. and Göttlinger, H. G. (1995). Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69, 3824-3830.
60. Zingler, K. and Littman, D. R. (1993). Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation ino particles and fusogenicity and infectivity. J. Virol. 67, 2824-2831.
61. Vzorov, A. N. and Compans, R. W. (1996). Assembly and release of SIV Env proteins with full-length or truncated cytoplasmic domains. Virology 221, 22-33.
62. Klimkait, T., Strebel, K., Hoggan, M. D., Martin, M. A. and Orenstein, J. M. (1990). The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64, 621-629.
63. Strebel, K., Klimkait, T. and Martin, M. A. (1988). A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241, 1221-1223.
64. Schubert, U., Bour, S., Ferrer-Montiel, A. V., Montai, M., Maldarell, F. and Strebel, K. (1996). The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70, 809-819.
65. Ewart, G. D., Sutherland, T., Gage, P. W. and Cox, G. B. (1996). The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 70, 7108-7115.
66. Göttlinger, H. G., Dorfman, T., Cohen, E. A. and Haseltine, W. A. (1993). Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc. Natl Acad. Sci. USA 90, 7381-7385.
67. Arroyo, J., Boceta, M., Gonzales, M. E., Michel, M. and Carrasco, L. (1995). Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41. J. Virol. 69, 4095-4102.
68. Chernomordik, L., Chanturiya, A. N., Suss-Toby, E., Nora, E. and Zimmerberg, J. (1994). An amphipatic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68, 7115-7123.
69. Miller, M. A. et al. (1993). Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196, 89-100.
70. Yang, C., Spies, C. P. and Compans, R. W. (1995). The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proc. Natl Acad. Sci. USA 92, 9871-9875.
71. Bour, S., Schubert, U., Peden, K. and Strebel, K. (1996). The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? J. Virol. 70, 820-829.
72. Ritter, G. D., Yamshchikov, G., Cohen, S. J. and Mulligan, M. J. (1996). Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: Role of the cytoplasmic domain. J. Virol. 70, 2669-2673.
73. Rolls, M. M., Webster, P., Balba, N. H. and Rose, J. K. (1994). Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA. Cell 79, 497-506.
74. Simons, K. and Fuller, S. D. (1985). Cell surface polarity in epithelia. Ann. Rev. Cell Biol. 1, 243-288.
75. Rodriguez-Boulan, E. and Nelson, W. J. (1989). Morphogenesis of the polarized epithelial cell phenotype. Science 245, 718-725.
76. Wandinger-Ness, A., Bennett, M. K., Antony, C. and Simons, K. (1990). Distinct transport vesicles mediate the delivery of plasma membrane proteins to the apical and basolateral domains of MDCK cells. J. Cell Biol. 111, 987-1000.
77. Thomas, D. C., Brewer, C. B. and Roth, M. G. (1993). Vesicular stomatitis virus glycoprotein contains a dominant cytoplasmic basolateral sorting signal critically dependent upon a tyrosine. J. Biol. Chem. 268, 3313-3320.
78. Stephens, E. B., Compans, R. W., Earl, P. and Moss, B. (1986). Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. EMBO J. 5, 237-245.
79. Brewer, C. B. and Roth, M. G. (1991). A single amino acid change in the cytoplasmic domain alters the polarized delivery of influenza virus hemagglutinin. J Cell Biol. 114, 413-421.
80. Lisanti, M. P. and Rodriguez-Boulan, E. (1990). Glycophosphohpid membrane anchoring provides clues to the mechanism of protein sorting in polarized epithelial cells. Trends Biochem. Sci. 15, 113-118.
81. Brown, D. A., Crise, B. and Rose, J. K. (1989). Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. Science 245, 1499-1501.
82. Breitfeld, P. P., McKinnon, W. C. and Mostov, K. E. (1990). Effect of nocodazole on vesicular traffic to the apical and basolateral surfaces of polarized MDCK cells. J. Cell Biol. 111, 2365-2373.
83. Simons, K. and Ikonen, E. (1997). Functional rafts in cell membranes. Nature 387, 569-572.
84. Onashi, M. et al. (1995). A role for phosphatidylinositol transfer protein in secretory vesicle formation. Nature 377, 544-547.
85. Liscovitch, M. and Cantley, L. C. (1995). Signal transduction and membrane traffic: The PITP/phosphoinositide connection. Cell 81, 659-662.
86. Mallabiabarrena, A. and Malhotra, V. (1995). Vesicle biogenesis: The coat connection. Cell 83, 667-669.
87. Nieva, J. L., Bron, R., Corver, J. and Wilschut, J. (1994). Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J. 13, 2797-2804.
88. Malvoisin, E. and Wild, F. (1990). Effect of drugs which inhibit cholesterol synthesis on syncytia formation in vero cells infected with measles virus. Biochim. Biophys. Acta 1042, 359-364.
89. Aloia, R. C., Tian, H. and Jensen, F. C. (1993). Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl Acad. Sci. USA 90, 5181-5185.